Cargando…
The Deubiquitinating Enzyme Inhibitor PR-619 is a Potent DNA Topoisomerase II Poison
2,6-Diaminopyridine-3,5-bis(thiocyanate) (PR-619) is a broad-spectrum deubiquitinating enzyme (DUB) inhibitor that has been employed in cell-based studies as a tool to investigate the role of ubiquitination in various cellular processes. Here, we demonstrate that in addition to its action as a DUB i...
Autores principales: | Cowell, Ian G., Ling, Elise M., Swan, Rebecca L., Brooks, Matilda L.W., Austin, Caroline A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776009/ https://www.ncbi.nlm.nih.gov/pubmed/31515282 http://dx.doi.org/10.1124/mol.119.117390 |
Ejemplares similares
-
The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study
por: Kuo, Kuan-Lin, et al.
Publicado: (2019) -
Inhibition of deubiquitination by PR‐619 induces apoptosis and autophagy via ubi‐protein aggregation‐activated ER stress in oesophageal squamous cell carcinoma
por: Wang, Longhao, et al.
Publicado: (2020) -
Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II
por: Lee, Ka C., et al.
Publicado: (2016) -
Mechanism of Generation of Therapy Related Leukemia in Response to Anti-Topoisomerase II Agents
por: Cowell, Ian G., et al.
Publicado: (2012) -
Deubiquitinating enzymes as oncotargets
por: McClurg, Urszula L., et al.
Publicado: (2015)